Ifluenza A Infections Market is driven by Vaccine Advancements
The Influenza A Infections Market encompasses a broad portfolio of preventive and therapeutic products, including seasonal and pandemic vaccines, antiviral drugs, monoclonal antibodies, and diagnostic assays. Vaccines such as inactivated, live-attenuated, and recombinant formulations are key offerings, providing adaptive immunity against circulating strains with high safety profiles. Antiviral...
0 Comments 0 Shares 38 Views 0 Reviews